Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 12

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 11,001–12,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
11001Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factorsUKBB000000580.01
11002Average total household income before tax | HouseholdUKBB000000810.01
11003FCAR/LY96 ratioGCST903147880.01
11004AMY2B levelsGCST904682990.01
11005ALPP levelsGCST904682860.01
11006Urine X-24798 levels in chronic kidney diseaseGCST902668020.01
11007Fruit likingGCST900947660.01
11008DAG1 levelsGCST904689430.01
11009FCRL5/LY96 ratioGCST903148030.01
11010Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459ECGA0004590.01
11011Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442ECGU0004420.01
11012ATF6 levelsGCST902408160.01
11013Seborrhoeic dermatitisFING000012820.01
11014CLPP levelsGCST904687850.01
11015DPP6/NELL2 ratioGCST903145410.01
11016Chicken likingGCST900947320.01
11017Insulin fold change during an oral glucose tolerance test (adjusted for BMI)GCST902675670.01
11018NPDC1 levelsGCST904700690.01
11019Saturated fatty acid levelsGCST900929800.01
11020Number of self-reported non-cancer illnesses | Medical conditionsUKBB000005410.01
11021Frequency of walking for pleasure in last 4 weeks | Physical activityUKBB000002710.01
11022Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING000011430.01
11023DOK2/GRAP2 ratioGCST903145310.01
11024DTI autoptx MD fma tractGCST903852300.01
11025F-capsicum liking (derived food-liking factor)GCST900947260.01
11026Type 2 diabetes, definitions combinedFING000013820.01
11027ObesityFING000008950.01
11028TCN2 levelsGCST904708200.01
11029Cholesteryl ester levels in large LDLGCST900928580.01
11030MMP9 levelsGCST904699230.01
11031F-burn/spicy liking (derived food-liking factor)GCST900947160.01
11032Thyroid stimulating hormone levels within normal range in pregnancyGCST904351950.01
11033Glycine levelsGCST904973150.01
11034FOLR3 levelsGCST904692610.01
11035T1 FreeSurfer aseg Right-CaudateGCST903841620.01
11036STX8 levelsGCST904707760.01
11037CA3 levelsGCST904685120.01
11038Occupation and workplace environment (confirmatory factor analysis Factor 5)GCST903093400.01
11039KIR2DL3 levelsGCST904696850.01
11040Nasal polypFING000008580.01
11041Total free cholesterol levelsGCST905000630.01
11042CXADR/MME ratioGCST903143290.01
11043BST2 levelsGCST904684750.01
11044Crohn's diseaseGCST904753180.01
11045IL1R1/IL1RN ratioGCST903151580.01
11046DBI/MESD ratioGCST903144090.01
11047Job involved shift work | Employment historyUKBB000003820.01
11048ICD10 O60: Preterm labor and deliveryGCST904542420.01
11049Loneliness (weighted GWA)GCST902672890.01
11050METAP2/PFKFB2 ratioGCST903154310.01
11051RAB31 levelsGCST900875520.01
11052TCL1A/TNFRSF13C ratioGCST903159120.01
11053Ulcerative colitis (strict) with PSCFING000013890.01
11054hematocrit (mean, inv-norm transformed)GCST904753410.01
11055Number of days/week of vigorous physical activity 10+ minutes | Physical activityUKBB000005340.01
11056HematocritGCST900187400.01
11057Diabetes (standard GWA)GCST902672780.01
11058LDL cholesterol levelsGCST900928830.01
11059ADAM15 levelsGCST904682170.01
11060CETN3 levelsGCST904687220.01
11061IGLC2 levelsGCST904695360.01
11062CCN2/TACC3 ratioGCST903137170.01
11063Operative procedures - No procedure performed | Summary OperationsUKBB000005840.01
11064PCOLCE levelsGCST904701750.01
11065CLC levelsGCST904687620.01
11066Chronic ulcer of skin, not elsewhere classifiedFING000003000.01
11067Diseases of white blood cells (PheCode 288)GCST904758120.01
11068Total lipid levels in large LDLGCST900928620.01
11069Gestational diabetes mellitusGCST905664190.01
11070EDAR/LAT2 ratioGCST903145820.01
11071Pollock likingGCST900948130.01
11072CSF1/IL10RB ratioGCST903142840.01
11073SEZ6 levelsGCST904706080.01
11074Other symptoms of respiratory system (PheCode 512)GCST904760390.01
11075REST UKBBICA NODEamps25 0009GCST903854920.01
11076REST UKBBICA NODEamps25 0021GCST903855040.01
11077Thyroid stimulating hormone levelsGCST902963330.01
11078CDKN2D/TACC3 ratioGCST903139920.01
11079Water consumption (glasses per day) (UKB data field 1528)GCST901329850.01
11080ERMAP levelsGCST904691470.01
11081Celiac disease (PheCode 557.1)GCST900441580.01
11082PPP1R2/TACC3 ratioGCST903157190.01
11083T1 FreeSurfer aseg rhCerebralWhiteMatterVolGCST903841860.01
11084rfMRI connectivity (ICA25 edge 101)GCST900047440.01
11085CD1C levelsGCST904686040.01
11086Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB000006130.01
11087FKBP5/MAP4K5 ratioGCST903148430.01
11088Globe artichoke likingGCST900947710.01
11089Fasting glucoseGCST902786280.01
11090Weight, inverse-rank normalizedFING000014470.01
11091Total lipid levels in LDLGCST900928860.01
11092WFDC1 levelsGCST904710740.01
11093CEACAM5 levelsGCST904686960.01
11094Myasthenia gravisGCST904321560.01
11095CPB1/CTRB1 ratioGCST903142080.01
11096Strawberries likingGCST900948490.01
11097Mean corpuscular hemoglobin concentrationGCST0046050.01
11098IDP T1 FAST ROIs L cerebellum VIIIaGCST900025780.01
11099lymphocyte (absolute count, maximum, inv-norm transformed)GCST904754230.01
11100Use of hypnotics and sedativesFING000014110.01
11101PCSK7 levelsGCST904701760.01
11102AK1 levelsGCST904682690.01
11103wg rh intensity-contrast cuneusGCST900038310.01
11104ARSA/GUSB ratioGCST903133550.01
11105Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428ECGU0004280.01
11106Type 1 diabetes (PheCode 250.1)GCST904756610.01
11107HCLS1/LAT ratioGCST903150410.01
11108MATN3 levelsGCST904698650.01
11109Main speciality of consultant (recoded) - Gastroenterology | Summary AdministrationUKBB000004150.01
11110FGF21/LEP ratioGCST903148100.01
11111Chronic airway obstruction (PheCode 496)GCST904760270.01
11112RETN/RNASET2 ratioGCST903157680.01
11113Disorders of skin appendagesFING000004600.01
11114CXCL5/SDC4 ratioGCST903143530.01
11115CD59/PI3 ratioGCST903138580.01
11116CRTAM/GZMA ratioGCST903142750.01
11117FGF23 levelsGCST904692230.01
11118SEMA4C levelsGCST904705720.01
11119Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST903093690.01
11120Biological Sibling: Cancer, SkinGCST904763690.01
11121Linoleic acid levelsGCST905020090.01
11122CSTB levelsGCST900120060.01
11123Operation code - appendicectomy | OperationsUKBB000005490.01
11124Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivityGCST903026720.01
11125Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448)GCST901329670.01
11126Ulcerative colitis (PheCode 555.2)GCST900441550.01
11127CXCL10/CXCL11 ratioGCST903143300.01
11128Other systemic involvement of connective tissue (FG)FING000011160.01
11129Nonsuppurative otitis mediaFING000008850.01
11130GUCA2A levelsGCST904694180.01
11131Principal component-derived dietary pattern 12GCST901330170.01
11132Lymphocyte countGCST900023880.01
11133Volume of right paralaminar nucleusGCST904750510.01
11134Ratio of saturated fatty acids to total fatty acidsGCST900929810.01
11135VAMP5 levelsGCST904710240.01
11136BTN2A1/SPINT2 ratioGCST903135500.01
11137HematocritGCST900023050.01
11138SIRT1 levelsGCST904706410.01
11139LY96/ST6GAL1 ratioGCST903153480.01
11140SERPINA9 levelsGCST904705880.01
11141IPCEF1/SMAD1 ratioGCST903151850.01
11142TNFRSF8 levelsGCST904709150.01
11143CALCOCO1/CASP3 ratioGCST903135960.01
11144Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448ECGU0004480.01
11145IDP dMRI TBSS ISOVF Posterior thalamic radiation RGCST900045050.01
11146AmygNuclei lh volume Lateral-nucleusGCST900026480.01
11147Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levelsGCST902000130.01
11148Aplastic anemia (PheCode 284)GCST904757830.01
11149TNFRSF1A/TNFRSF1B ratioGCST903159370.01
11150BMI and adiposity (confirmatory factor analysis Factor 7)GCST903093420.01
11151Early onset COPDFING000004850.01
11152Physical activity (Total log acceleration)GCST900614080.01
11153DNMBP/WWP2 ratioGCST903145220.01
11154DermatitisFING000004010.01
11155Pain in limbFING000011380.01
11156Asthma (childhood onset)GCST0078000.01
11157ATXN10/PRTFDC1 ratioGCST903133980.01
11158ThalamNuclei lh volume CMGCST900027180.01
11159Brainstem global volume MidbrainGCST900027670.01
11160MMP1/SERPINB6 ratioGCST903154620.01
11161ABHD14B/CRADD ratioGCST903131410.01
11162Cake icing likingGCST900947230.01
11163CCL5/TACC3 ratioGCST903137070.01
11164Lymphocyte count (UKB data field 30120)GCST904680820.01
11165Respiratory disease (confirmatory factor analysis Factor 11)GCST903093450.01
11166NEFL levelsGCST904700240.01
11167Raw vegetable consumptionGCST901329780.01
11168Principal component-derived dietary pattern 18GCST901330230.01
11169IDP dMRI ProbtrackX ICVF str rGCST900043990.01
11170Skin cancerGCST904751899.99e-03
11171Degree of unsaturationGCST905027469.99e-03
11172Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903027239.99e-03
11173Age first had sexual intercourse | Sexual factorsUKBB000000149.98e-03
11174T1 FreeSurfer aseg Left-CaudateGCST903841449.98e-03
11175Seropositive rheumatoid arthritis, wideFING000012989.98e-03
11176F-highly palatable foods liking (derived food-liking factor)GCST900947859.97e-03
11177Acceptance of an invitation to wear a physical activity monitorGCST900127919.97e-03
11178Frailty indexGCST900200539.97e-03
11179EGF/MPIG6B ratioGCST903146119.96e-03
11180Treatment/medication code - omeprazole | MedicationsUKBB000008529.96e-03
11181Own or rent accommodation lived in - Own outright (by you or someone in your household) | HouseholdUKBB000006239.94e-03
11182PLA2G15 levelsGCST904702459.94e-03
11183Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T484ECGA0004849.94e-03
11184Total fatty acid levelsGCST900929879.94e-03
11185CD74/TIMD4 ratioGCST903138969.94e-03
11186EDAR/TMSB10 ratioGCST903145909.91e-03
11187Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T220ECGA0002209.90e-03
11188Lichen sclerosus et atrophicusFING000007239.87e-03
11189TSC1 levelsGCST904709729.87e-03
11190Immature fraction of reticulocytesGCST0046289.87e-03
11191CREG1/GUSB ratioGCST903142499.87e-03
11192EDAR/TACC3 ratioGCST903145899.86e-03
11193FAM3B/GUCA2A ratioGCST903147799.86e-03
11194Beans likingGCST900946999.85e-03
11195BTN2A1/IFNGR1 ratioGCST903135439.84e-03
11196Clonal hematopoiesis (large clone)GCST901026219.83e-03
11197EBAG9/MITD1 ratioGCST903145669.83e-03
11198MAVS/MED18 ratioGCST903153899.83e-03
11199Obesity, other/unspecifiedFING000008989.82e-03
11200CD27/NBL1 ratioGCST903137749.81e-03
11201F-fatty/dairy food liking (derived food-liking factor)GCST900947609.81e-03
11202Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449ECGU0004499.80e-03
11203Number of fluid intelligence questions attempted within time limit | Fluid intelligence / reasoningUKBB000005379.80e-03
11204HippSubfield lh volume Hippocampal-tailGCST900026689.79e-03
11205PEAR1/SPINT2 ratioGCST903156449.79e-03
11206INSR levelsGCST904696239.75e-03
11207Mineral and other dietary supplements - Fish oil (including cod liver oil) | MedicationUKBB000004729.74e-03
11208CD19 on IgD- CD38- B cellGCST900017339.74e-03
11209Fasting blood glucoseGCST0051869.73e-03
11210Poultry consumptionGCST901329969.73e-03
11211CTRB1/PLA2G1B ratioGCST903143079.71e-03
11212Cholesteryl esters to total lipids ratio in small VLDLGCST900929719.69e-03
11213LGALS4/TIE1 ratioGCST903153169.68e-03
11214CPB1/REG1B ratioGCST903142139.67e-03
11215Hemorrhagic fever with renal syndromeGCST904541909.62e-03
11216Alzheimer's diseaseGCST900271589.62e-03
11217Frailty (Factor 2 - Unhealthy Lifestyle)GCST906240489.60e-03
11218IL15/KLRD1 ratioGCST903151499.58e-03
11219Type 2 diabetesGCST900860719.58e-03
11220ART3/RGMB ratioGCST903133639.55e-03
11221Diseases of liverFING000004259.55e-03
11222STC2 levelsGCST904707629.54e-03
11223SLAMF1 levelsGCST904706499.51e-03
11224Reason for reducing amount of alcohol drunk - Other reason | AlcoholUKBB000007359.51e-03
11225CXCL5/SERPINE1 ratioGCST903143549.50e-03
11226Systemic connective tissue disordersFING000013509.49e-03
11227Insomnia complaintsGCST0064889.48e-03
11228CDH15 levelsGCST904686689.41e-03
11229Principal component-derived dietary pattern 3GCST901330089.41e-03
11230SEMA4D/TREML2 ratioGCST903158239.40e-03
11231CD14 levelsGCST904685989.39e-03
11232Cancer of prostate (PheCode 185)GCST904755919.38e-03
11233RETN levelsGCST900120349.35e-03
11234Basal cell carcinoma (MTAG)GCST901374119.34e-03
11235GPR15L levelsGCST904693969.34e-03
11236CDH1/CDH17 ratioGCST903139459.32e-03
11237Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441ECGU0004419.31e-03
11238DTI autoptx L1 ptr r tractGCST903851599.30e-03
11239wg lh intensity-contrast lingualGCST900038049.30e-03
11240Gastritis and duodenitis | digestiveUKBB000002779.29e-03
11241Bread type: White (UKB data field 1448_1)GCST901329649.27e-03
11242All influenzaFING000000649.25e-03
11243Ulcerative colitisGCST904753229.24e-03
11244Melanoma in situ (controls excluding all cancers)FING000008039.22e-03
11245CCL4 levelsGCST0044339.20e-03
11246Time spend outdoors in summer | Sun exposureUKBB000008179.19e-03
11247DBNL/HSPA1A ratioGCST903144189.18e-03
11248Physical activity (Total log acceleration 12am-2am)GCST900614099.17e-03
11249Cancer of prostate (PheCode 185)GCST900418539.17e-03
11250ANGPT1/CCN2 ratioGCST903132619.14e-03
11251IDP dMRI TBSS L1 Posterior limb of internal capsule LGCST900040949.13e-03
11252TGFB1 levelsGCST902748189.10e-03
11253Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB000005099.09e-03
11254Illnesses of siblings - Diabetes | Family historyUKBB000003509.08e-03
11255CD69/EDAR ratioGCST903138759.08e-03
11256Ectropion or entropion (PheCode 374.1)GCST904758919.07e-03
11257MAP4K5/STAMBP ratioGCST903153829.06e-03
11258CXCL10 levelsGCST902747809.06e-03
11259Illness, injury, bereavement, stress in last 2 years - None of the above | Mental healthUKBB000003399.05e-03
11260mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754529.05e-03
11261Melanomas of skin (PheCode 172.11)GCST904755789.03e-03
11262FOXO1/IRAK4 ratioGCST903148709.03e-03
11263Oxalate (ethanedioate) levelsGCST901996728.99e-03
11264Erythematosquamous dermatosis (PheCode 690)GCST904761708.98e-03
11265BronchitisFING000002288.97e-03
11266T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54)GCST903206178.96e-03
11267CRADD/FKBP4 ratioGCST903142388.96e-03
11268CD207 levelsGCST904686078.96e-03
11269Severe, life-threatening illness (confirmatory factor analysis Factor 20)GCST903093548.96e-03
11270Ceramide (d18:1/24:0) levelsGCST900240468.94e-03
11271ITIH3 levelsGCST904696508.93e-03
11272PTPRF/SDC1 ratioGCST903157528.93e-03
11273Pain type(s) experienced in last month - Pain all over the body | PainUKBB000006328.93e-03
11274Diseases of middle ear and mastoidFING000004278.91e-03
11275Age at first birthGCST900000508.89e-03
11276BA-exvivo rh area BA4pGCST900032268.87e-03
11277KIFBP/LYN ratioGCST903152468.86e-03
11278Prostate cancerGCST902747148.86e-03
11279Cardiometabolic multimorbidityGCST902747238.86e-03
11280Triglycerides to total lipids ratio in chylomicrons and extremely large VLDLGCST900930518.85e-03
11281CHI3L1/PRSS8 ratioGCST903140448.83e-03
11282TNFSF11 levelsGCST902748448.83e-03
11283HS6ST2 levelsGCST904694808.82e-03
11284Alcohol likingGCST900946888.78e-03
11285LAIR1 levelsGCST904697288.77e-03
11286CD300C/NBL1 ratioGCST903137928.76e-03
11287CRLF1 levelsGCST904688688.75e-03
11288Coffee intake | DietUKBB000001388.74e-03
11289FAM177A1 levelsGCST902424588.73e-03
11290PAEP levelsGCST904701448.72e-03
11291Skin luminanceGCST903202578.71e-03
11292CDKN1A/YES1 ratioGCST903139808.71e-03
11293Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000006418.71e-03
11294CRYGD levelsGCST904688768.70e-03
11295Nonspecific chest pain | circulatory systemUKBB000005278.70e-03
11296LGALS4/PCDH17 ratioGCST903153158.67e-03
11297Mean corpuscular hemoglobin concentrationGCST900023288.67e-03
11298IDP T1 SIENAX grey normalised volumeGCST900024308.66e-03
11299LBR/LGALS8 ratioGCST903152948.66e-03
11300HyperthyroidismGCST903193198.64e-03
11301Water intake | DietUKBB000009068.61e-03
11302CFHR2 levelsGCST904687268.60e-03
11303Usual side of head for mobile phone use - Left | Electronic device useUKBB000008898.59e-03
11304Handedness (confirmatory factor analysis Factor 36)GCST903093708.58e-03
11305T1 FreeSurfer a2009s lh S postcentral areaGCST903847348.57e-03
11306Benign neoplasm of skin (PheCode 216)GCST904756208.56e-03
11307Prevotella sp000434975 abundance in stoolGCST900325188.56e-03
11308Creatinine levels (UKB data field 23478)GCST902695758.55e-03
11309AXIN1/SRPK2 ratioGCST903134178.53e-03
11310eosinophil (absolute count, mean, inv-norm transformed)GCST904752918.52e-03
11311Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST906685188.51e-03
11312Sources of admission to hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000007868.49e-03
11313Psoriatic arthritis vs Cutaneous psoriasisGCST902439578.49e-03
11314Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers)FING000008438.49e-03
11315Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB000000598.49e-03
11316MYOM2 levelsGCST904699858.47e-03
11317Treatment/medication code - aspirin | MedicationsUKBB000008418.47e-03
11318Phosphatidylethanolamine (18:0_18:1) levelsGCST900249778.46e-03
11319WeightGCST900187298.45e-03
11320sodium (minimum, inv-norm transformed)GCST904763978.43e-03
11321ITGB5/SIAE ratioGCST903152348.43e-03
11322IDP dMRI ProbtrackX ISOVF ifo rGCST900045388.42e-03
11323Eosinophill count | Blood countUKBB000002068.41e-03
11324CST3/IL18BP ratioGCST903142948.41e-03
11325CDKN1A/HBEGF ratioGCST903139728.41e-03
11326Hypothyroidism, drug reimbursementFING000006558.40e-03
11327CXCL3/CXCL5 ratioGCST903143448.38e-03
11328HSIL lesion of the cervix uteri, vagina or vulvaFING000006258.38e-03
11329BSG levelsGCST904684728.37e-03
11330BLVRB/CA1 ratioGCST903135218.35e-03
11331Platelet count (UKB data field 30080)GCST904680958.35e-03
11332Platelet countGCST0046038.35e-03
11333Total Dihexosylceramide levelsGCST900251938.33e-03
11334CRYBB1 levelsGCST904688748.31e-03
11335Fluid intelligence score decline (difference score)GCST905658628.28e-03
11336CD84/F2R ratioGCST903139128.28e-03
11337IDP dMRI TBSS OD Cerebral peduncle RGCST900044168.28e-03
11338Allergic asthma (mode)FING000000668.28e-03
11339CRADD/DARS1 ratioGCST903142348.27e-03
11340CFC1 levelsGCST904687248.27e-03
11341CCBL2 levelsGCST902417228.25e-03
11342ATOX1/TMSB10 ratioGCST903133778.24e-03
11343Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST901329668.23e-03
11344Moderate to vigorous physical activity durationGCST900614228.23e-03
11345DKK1/SDC4 ratioGCST903144798.22e-03
11346White blood cell countGCST900187588.22e-03
11347TNFRSF1B levelsGCST904709118.22e-03
11348Gastroesophageal reflux diseaseGCST900005148.18e-03
11349Other non-epithelial cancer of skin | neoplasmsUKBB000006158.16e-03
11350HGFAC levelsGCST904694488.15e-03
11351CPA1/PLA2G1B ratioGCST903142058.14e-03
11352DTI autoptx L3 ptr r tractGCST903852138.14e-03
11353Leisure/social activities - Other group activity | Social supportUKBB000004008.14e-03
11354Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008468.13e-03
11355Sensorineural hearing lossFING000012918.13e-03
11356FKBP4/RWDD1 ratioGCST903148408.12e-03
11357Gastritis and duodenitis | Diseases of oesophagus, stomach and duodenumUKBB000002788.11e-03
11358aparc-DKTatlas rh volume precuneusGCST900029168.11e-03
11359KIF22 levelsGCST904696828.10e-03
11360SIGLEC10 levelsGCST904706308.10e-03
11361DTI TBSS L1 Posterior limb of internal capsule RGCST903844468.09e-03
11362HypothyroidismGCST900186428.09e-03
11363CALCOCO1/CASP8 ratioGCST903135978.05e-03
11364Leisure screen timeGCST901043398.04e-03
11365CCL4 levelsGCST904685838.03e-03
11366PYY levelsGCST904703988.03e-03
11367TIA1/USP8 ratioGCST903159208.02e-03
11368PARP1/TCL1A ratioGCST903156028.00e-03
11369Body fat rateGCST902786197.99e-03
11370IL22RA2 levelsGCST900906997.98e-03
11371Aniseed likingGCST900946897.98e-03
11372Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivityGCST903026737.93e-03
11373SCN4B levelsGCST904705517.91e-03
11374ICAM2/SELE ratioGCST903151207.91e-03
11375AsthmaGCST904681127.91e-03
11376PDGFB/SNAP29 ratioGCST903156277.90e-03
11377Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440ECGU0004407.90e-03
11378Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000157.89e-03
11379AARSD1/PIK3AP1 ratioGCST903131297.88e-03
11380ITGB1BP2/USP8 ratioGCST903152237.88e-03
11381Migraine with aura and triptan purchasesFING000008207.86e-03
11382Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T467ECGA0004677.85e-03
11383CNPY4/MESD ratioGCST903141527.85e-03
11384TOP1 levelsGCST904709337.84e-03
11385HAVCR2 levelsGCST904694327.83e-03
11386Papulosquamous disordersFING000011447.83e-03
11387Mucosal proctocolitisFING000008417.82e-03
11388Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09)GCST902913127.82e-03
11389Scar conditions and fibrosis of skin (PheCode 701.2)GCST904761987.81e-03
113901-stearoyl-GPE (18:0) levelsGCST901997727.80e-03
11391Waist circumferenceGCST902786487.80e-03
11392EPHB6 levelsGCST904691337.80e-03
11393CD164/LGMN ratioGCST903137417.80e-03
11394Mean corpuscular hemoglobin concentrationGCST900023917.80e-03
11395CD27/DLL1 ratioGCST903137717.78e-03
11396Sicca syndrome [Sjögren]FING000013047.77e-03
11397Obesity due to excess caloriesFING000008967.75e-03
11398FXN/METAP1D ratioGCST903148977.74e-03
11399GUCA2A/LGALS4 ratioGCST903149987.73e-03
11400Continuous positive airway pressureFING000003497.72e-03
11401CLEC4G/SEMA3F ratioGCST903141237.69e-03
11402SEMA4D levelsGCST904705737.67e-03
11403Lymphoid neoplasms (B-cell phenocluster)GCST906247367.67e-03
11404Potassium in urine | Urine assaysUKBB000006557.66e-03
11405Takes medication for asthma?GCST904752607.65e-03
11406Educational attainmentGCST0034967.64e-03
11407Eosinophil countGCST900187337.64e-03
11408T1 FreeSurfer BA rh BA3a exvivo thicknessGCST903855637.64e-03
11409Type 1 diabetes, definitions combinedFING000013807.63e-03
11410SERPINA7 levelsGCST904705877.62e-03
11411EDAR/TREML2 ratioGCST903145927.61e-03
11412EDAR/PSRC1 ratioGCST903145847.61e-03
11413Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST904752757.61e-03
11414BTN2A1 levelsGCST904684807.60e-03
11415Free Cholesterol to Total Lipids in Small HDL percentageGCST904994317.60e-03
11416DTI TBSS MO Medial lemniscus RGCST903846287.59e-03
11417Chest pain or discomfort | Chest painUKBB000001287.59e-03
11418Ectopic pregnancyFING000004877.59e-03
11419ERBIN/LYN ratioGCST903146947.58e-03
11420Lymphocyte countGCST0046277.57e-03
11421ICAM4 levelsGCST904695017.56e-03
11422Blood cell traits latent factor 12 (red cell)GCST905592547.56e-03
11423CDH17/PECAM1 ratioGCST903139427.56e-03
11424CD84/SDC4 ratioGCST903139167.56e-03
11425Multiple myelomaGCST906247477.55e-03
11426Prurigo nodularisFING000012207.54e-03
11427Bundle branch block (PheCode 426.3)GCST904759567.52e-03
11428KLRB1 levelsGCST904697097.52e-03
11429CST3/CTSZ ratioGCST903142907.51e-03
11430Ulcerative colitisGCST0041337.51e-03
11431Lymphoid neoplasms (drug group 1 phenocluster)GCST906247407.50e-03
11432LIPF levelsGCST904697807.48e-03
11433Lymphocyte count | Blood countUKBB000004117.46e-03
11434Urinary incontinence (PheCode 599.4)GCST904761527.42e-03
11435DCTN6/TDRKH ratioGCST903144367.42e-03
11436Free cholesterol levels in very large HDLGCST901326807.41e-03
11437Saturated fatty acids to total fatty acids percentage (UKB data field 23455)GCST902695527.40e-03
11438CCL17/GRK5 ratioGCST903136877.39e-03
11439SDC4/SERPINE1 ratioGCST903158197.39e-03
11440CSF2 levelsGCST904688847.39e-03
11441CTSS levelsGCST904689167.37e-03
11442TXNDC15 levelsGCST904709907.37e-03
11443Types of transport used (excluding work) - Walk | Physical activityUKBB000008797.37e-03
11444Other Crohn's diseaseFING000009927.36e-03
11445rfMRI connectivity ICA-features 1GCST900063397.34e-03
11446EDAR/EGF ratioGCST903145737.34e-03
11447Cholelithiasis and cholecystitis | digestiveUKBB000001337.31e-03
11448CA4/TNFSF12 ratioGCST903135897.29e-03
11449F2R/GP6 ratioGCST903147307.29e-03
11450ATF6 levelsGCST906172607.28e-03
11451Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney diseaseGCST902659717.28e-03
11452CA4/FOLR2 ratioGCST903135857.26e-03
11453Glycine levelsGCST0076387.26e-03
11454DTI TBSS L3 Anterior limb of internal capsule RGCST903845407.25e-03
11455KLK14 levelsGCST904697007.24e-03
11456Intended management of patient (recoded) - No overnight hospital stay | Summary AdministrationUKBB000003667.23e-03
11457AsthmaGCST904760247.22e-03
11458Pain (limb, back, neck, head abdominally)FING000011357.22e-03
11459CA2/CA3 ratioGCST903135767.21e-03
11460Other functional intestinal disordersFING000010527.20e-03
11461Other and unspecified nerve root and plexus disorders, also in other diseasesFING000009447.20e-03
11462Hypo-osmolality and hyponatraemiaFING000006487.18e-03
11463Birth year infant mortality ratesGCST900950477.18e-03
11464ICD10 D25: Leiomyoma of uterusGCST904542047.17e-03
11465UMOD levelsGCST904710097.16e-03
11466EFHD1 levelsGCST904690797.16e-03
11467CD79B/ICAM3 ratioGCST903139017.15e-03
11468Beef/steak likingGCST900947007.14e-03
11469CAPS levelsGCST904685397.14e-03
11470CALCOCO1/PFKFB2 ratioGCST903136087.13e-03
11471Pregnenolone sulfate levelsGCST901998737.13e-03
11472Hypercalcemia (PheCode 275.6)GCST904757487.12e-03
11473Single spontaneous deliveryFING000013077.12e-03
11474Atrial fibrillation and flutter (PheCode 427.2)GCST900439777.12e-03
11475DTI TBSS L1 Anterior corona radiata RGCST903844507.10e-03
11476Sodium (mean, inv-norm transformed)GCST904763957.09e-03
11477CPA2 levelsGCST904688377.08e-03
11478QSOX1 levelsGCST904704027.06e-03
11479Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB000001017.05e-03
11480ITGA6/THPO ratioGCST903152087.04e-03
11481Second line medication for Crohn's diseaseFING000012847.03e-03
11482PDZK1 levelsGCST904702037.02e-03
11483ENO2/ITGB1BP2 ratioGCST903146617.02e-03
11484TSPAN1 levelsGCST904709787.00e-03
11485DNAJA2/HCLS1 ratioGCST903145026.99e-03
11486PADI4 levelsGCST904701436.99e-03
11487Myocardial fractal dimension (slice 2)GCST900002886.97e-03
11488CSNK1D levelsGCST904688886.97e-03
11489LEP levelsGCST904697576.95e-03
11490REG3A levelsGCST904704496.95e-03
11491Volume of left medial nucleusGCST904749766.95e-03
11492MGLL/MITD1 ratioGCST903154366.92e-03
11493Gamma-CEHC glucuronide levelsGCST901999416.90e-03
11494Blood cell traits latent factor 13 (red cell)GCST905592556.90e-03
11495CD160/KLRB1 ratioGCST903137316.90e-03
11496Usual side of head for mobile phone use - Right | Electronic device useUKBB000008906.90e-03
11497Vitamin D levelsGCST0053676.88e-03
11498ITGAL levelsGCST904696376.87e-03
11499PLXNB2 levelsGCST902422996.87e-03
11500IL18 levelsGCST904284116.87e-03
11501SLAMF1 levelsGCST902748356.85e-03
11502Blood cell traits latent factor 2 (red cell)GCST905592446.83e-03
11503CCL5/RARRES2 ratioGCST903137046.82e-03
11504HAVCR2/TNFRSF1B ratioGCST903150306.82e-03
11505Lamb likingGCST900947906.81e-03
11506CD74/IL18BP ratioGCST903138926.80e-03
11507LAYN/VWC2 ratioGCST903152936.80e-03
11508CD69/PLXNA4 ratioGCST903138806.79e-03
11509Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466ECGA0004666.79e-03
11510MS-disease / Multiple SclerosisFING000008396.77e-03
11511Depressive episode | Mood [affective] disordersUKBB000001666.76e-03
11512Ever highly irritable/argumentative for 2 days | Mental healthUKBB000002196.75e-03
11513Seropositive rheumatoid arthritis, strict definitionFING000012976.75e-03
11514PDGFB/VEGFC ratioGCST903156356.74e-03
11515FCRL6 levelsGCST904692096.74e-03
11516CD300E/CD59 ratioGCST903137946.74e-03
11517Eosinophil countGCST900259876.74e-03
11518Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10)GCST902918056.73e-03
11519Diacylglycerol_42:7_[M+H-H2O]1+ levelsGCST900602266.72e-03
11520Type of accommodation lived in - A house or bungalow | HouseholdUKBB000008696.71e-03
11521Glucose levelsGCST900187356.70e-03
11522Wheeze or whistling in the chest in last year | BreathingUKBB000009126.70e-03
11523Trauma exposureGCST0099826.69e-03
11524aseg rh volume Cerebellum-White-MatterGCST900026356.65e-03
11525Lymphoid leukaemia (controls excluding all cancers)FING000007416.64e-03
11526PIK3AP1 levelsGCST904702336.63e-03
11527Treatment or medication use - metformin (UKB data field 20003_1140884600)GCST900422456.62e-03
11528CD300C/CLEC14A ratioGCST903137866.61e-03
11529FCGR2B levelsGCST904692016.59e-03
11530AsthmaGCST900185756.59e-03
11531ThalamNuclei lh volume VLpGCST900027346.56e-03
11532OSCAR/TNFRSF14 ratioGCST903155886.56e-03
11533CD27/ICAM3 ratioGCST903137736.52e-03
11534EPHA2 levelsGCST904691306.51e-03
11535Basophil countGCST900022926.51e-03
11536F-fruit liking (derived food-liking factor)GCST900947676.50e-03
11537AMY2A levelsGCST904682986.50e-03
11538Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levelsGCST902000336.47e-03
11539neutrophil (fraction, minimum, inv-norm transformed)GCST904755416.47e-03
11540CANT1/VSIR ratioGCST903136216.45e-03
11541ENO2/HCLS1 ratioGCST903146606.44e-03
11542Physical activityGCST900933226.44e-03
11543Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB000008726.43e-03
11544PCDH17/SEMA7A ratioGCST903156056.43e-03
11545DKK1/IPCEF1 ratioGCST903144716.42e-03
11546GBP1 levelsGCST904693116.40e-03
11547Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000001676.36e-03
11548eosinophil (absolute count, maximum, inv-norm transformed)GCST904752886.32e-03
11549IFI30 levelsGCST904695096.32e-03
11550TFF3 levelsGCST904708376.28e-03
11551Basophil count varianceGCST905656826.27e-03
11552CTF1/ITGB1BP2 ratioGCST903143056.26e-03
11553Generalized epilepsyFING000005676.25e-03
11554eGFR in diabetes mellitus (strict) case-control group (minimal adjustment)GCST906247816.25e-03
11555Monocyte countGCST900023416.24e-03
11556CHMP1A/RHOC ratioGCST903140536.24e-03
11557LAT2/YES1 ratioGCST903152826.23e-03
11558Eosinophill percentage (UKB data field 30210)GCST904680696.23e-03
11559ANXA3/EDAR ratioGCST903132806.21e-03
11560TPP1 levelsGCST904709466.21e-03
11561SKAP1 levelsGCST904706456.21e-03
11562CDH17/SPINT1 ratioGCST903139446.18e-03
11563Acute upper respiratory infectionsFING000000346.18e-03
11564Apple juice likingGCST900946906.18e-03
11565Accelerometer-based physical activity measurement (average acceleration)GCST0060996.18e-03
11566Ratio of omega-6 fatty acids to total fatty acidsGCST900929356.17e-03
11567CA3/HMBS ratioGCST903135846.16e-03
11568Lysophosphatidylcholine (26:0) [sn2] levelsGCST900254286.15e-03
11569Neurofibromatosis, type 2FING000008676.14e-03
11570Fibrosis and cirrhosis of liverFING000005436.13e-03
11571Cancer of kidney and renal pelvis (PheCode 189.1)GCST904755956.13e-03
11572Other diseases of upper respiratory tractFING000010126.09e-03
11573FGF21 levelsGCST902747886.08e-03
11574Graves disease, strict definitionFING000005926.08e-03
11575NPTX2 levelsGCST904700796.07e-03
11576Bicarbonate (maximum, inv-norm transformed)GCST904751456.07e-03
11577Non-ischemic cardiomyopathyFING000008736.07e-03
11578AFP levelsGCST904682506.06e-03
11579MMP1 levelsGCST904699196.06e-03
11580Chronic sinusitisFING000002986.06e-03
11581KLRK1 levelsGCST904697136.05e-03
11582Eosinophill percentage | Blood countUKBB000002076.04e-03
11583ADH4/DCXR ratioGCST903131906.02e-03
11584Enthesopathy (PheCode 726.1)GCST904762396.02e-03
11585CPXM1/HBEGF ratioGCST903142196.02e-03
11586N6,N6-dimethyllysine levels in chronic kidney diseaseGCST902575296.01e-03
11587FCRL1/TREML2 ratioGCST903147975.99e-03
11588aparc-Desikan rh volume precuneusGCST900028255.98e-03
11589Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST901322275.97e-03
11590CD244/EDAR ratioGCST903137645.95e-03
11591Trauma (confirmatory factor analysis Factor 9)GCST903093435.95e-03
11592Multi-trait sum scoreGCST902701195.94e-03
11593Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462ECGA0004625.94e-03
11594NOTCH1/SEMA7A ratioGCST903155455.93e-03
11595MEP1B levelsGCST904698885.93e-03
11596Handedness (chirality/laterality) - Right-handed | Early life factorsUKBB000003035.93e-03
11597KLRB1/KLRD1 ratioGCST903152605.92e-03
11598Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING000013885.91e-03
11599Neutrophil percentage of granulocytesGCST0046235.90e-03
11600Rash and other nonspecific skin eruption (PheCode 687.1)GCST904761675.90e-03
11601CRELD2/ERP44 ratioGCST903142535.89e-03
11602BCR/CLIP2 ratioGCST903134865.87e-03
11603Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST900422265.87e-03
11604PLXNB2/SEMA7A ratioGCST903156925.85e-03
11605Basophil countGCST900022935.82e-03
11606TMPRSS15 levelsGCST904708925.81e-03
11607DCXR/SCLY ratioGCST903144405.81e-03
11608aseg rh volume VentralDCGCST900026445.81e-03
11609GRAP2/SRC ratioGCST903149895.81e-03
11610Skin cancer | neoplasmsUKBB000007725.79e-03
11611CRTAM/KLRD1 ratioGCST903142775.78e-03
11612Reason for reducing amount of alcohol drunk - Health precaution | AlcoholUKBB000007345.78e-03
11613PTPRR levelsGCST904703865.78e-03
11614Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary AdministrationUKBB000004665.77e-03
11615GP1BA/SIAE ratioGCST903149595.77e-03
11616FKBP4/WWP2 ratioGCST903148425.76e-03
11617CRTAP levelsGCST904688725.73e-03
11618PSRC1/SORT1 ratioGCST903157425.73e-03
11619HSIL lesion of the vulvaFING000006265.73e-03
11620T1 CAT volume L PlanumPolareGCST903840865.72e-03
11621Operative procedures - Total cholecystectomy NEC | Summary OperationsUKBB000005895.71e-03
11622Cholelithiasis | digestiveUKBB000001315.68e-03
11623AXIN1/GOPC ratioGCST903134075.68e-03
11624GOPC/IRAK4 ratioGCST903149545.68e-03
11625TNFSF10 levelsGCST904709175.67e-03
11626DAB2/GRAP2 ratioGCST903143645.65e-03
11627MEP1A levelsGCST904698875.65e-03
11628PsoriasisFING000012225.64e-03
11629Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T246ECGU0002465.64e-03
11630Basophil countGCST900259975.63e-03
11631CD200/CLEC4G ratioGCST903137465.63e-03
11632AmygNuclei rh volume Whole-amygdalaGCST900026675.63e-03
11633Wheeze or whistling in the chest in last year (UKB data field 2316)GCST900436145.62e-03
11634NADK levelsGCST904699935.62e-03
11635KIR3DL1 levelsGCST904696875.62e-03
11636Eosinophill count (UKB data field 30150)GCST904680685.61e-03
11637LAYN/TNFRSF4 ratioGCST903152915.61e-03
11638Broad bean likingGCST900947115.61e-03
11639Body mass indexGCST902786225.61e-03
11640Peptic ulcer (excl. esophageal) | digestiveUKBB000006395.59e-03
11641Syncope and collapse | symptomsUKBB000008015.59e-03
11642Triacylglycerol_54:3_[M+NH4]1+ levelsGCST900605415.57e-03
11643ThalamNuclei rh volume CMGCST900027425.56e-03
11644aseg rh volume AmygdalaGCST900026425.53e-03
11645ITIH4 levelsGCST904696515.53e-03
11646Depression medicationsFING000003995.52e-03
11647Diseases of hair and hair follicles (PheCode 704)GCST904762095.51e-03
11648IDP dMRI TBSS ICVF Tapetum LGCST900043745.50e-03
11649Ever taken cannabis | Cannabis useUKBB000002245.49e-03
11650CC2D1A/CRADD ratioGCST903136635.49e-03
11651MAP3K5/ZBTB16 ratioGCST903153805.49e-03
11652DARS1/MAP4K5 ratioGCST903144045.48e-03
11653Pain in joint (PheCode 745)GCST904762625.47e-03
11654Coeliac diseaseGCST904681205.47e-03
11655DTI TBSS MD Cingulum cingulate gyrus LGCST903846075.45e-03
11656Asthma, unspecified (mode)FING000001205.44e-03
11657CCL25/PRSS27 ratioGCST903136945.38e-03
11658CD36 levelsGCST904686275.36e-03
11659SIGLEC1 levelsGCST904706325.35e-03
11660Psoriasis vulgarisFING000012245.35e-03
11661Alkylphosphatidylcholine (O-34:1) levelsGCST900249255.35e-03
11662CRKL/MANF ratioGCST903142695.34e-03
11663Colon cancer/rectal cancerGCST904751705.34e-03
11664IPCEF1/SPARC ratioGCST903151865.34e-03
11665rfMRI amplitudes (ICA100 node 7)GCST900045955.34e-03
11666F-wine liking (derived food-liking factor)GCST900948725.33e-03
11667CA1/CA3 ratioGCST903135725.32e-03
11668hemoglobin (minimum, inv-norm transformed)GCST904753805.30e-03
11669DOK2/PPP1R2 ratioGCST903145375.27e-03
11670NPHS1 levelsGCST904700705.26e-03
11671Eosinophil countGCST900023815.26e-03
11672MAPRE3 levelsGCST904698595.25e-03
11673PRSS2 levelsGCST902431265.25e-03
11674Eosinophil percentage of granulocytesGCST0046175.24e-03
11675Autoimmune diseases excluding thyroid diseasesFING000001325.22e-03
11676Reimbursement for rheumatic diseasesFING000012475.20e-03
11677NCK2/VASH1 ratioGCST903155265.19e-03
11678CXCL1 levelsGCST900120195.18e-03
11679APRT/CD63 ratioGCST903133345.17e-03
11680NECTIN2/NPDC1 ratioGCST903155285.17e-03
11681Eosinophil countGCST900022985.17e-03
11682Eosinophil percentage of white cellsGCST0046005.15e-03
11683Early-onset myasthenia gravisGCST900934655.12e-03
11684Disorder of skin and subcutaneous tissue NO (PheCode 689)GCST904761695.11e-03
11685Epstein-Barr virus ZEBRA antibody levelsGCST900069015.11e-03
11686Disorders of orbitFING000004495.11e-03
11687CEACAM1/GGT1 ratioGCST903140005.11e-03
11688hematocrit (minimum, inv-norm transformed)GCST904753445.09e-03
11689MAVS/MZT1 ratioGCST903153915.08e-03
11690Coffee intake (standard GWA)GCST902672745.04e-03
11691Bread type - White | DietUKBB000001065.02e-03
11692Glycated hemoglobin levelsGCST900022445.01e-03
11693IDP T1 SIENAX peripheral grey normalised volumeGCST900024265.01e-03
11694Biological Sibling: AsthmaGCST904763725.00e-03
11695CD163/IL18BP ratioGCST903137364.98e-03
11696SCGB3A2 levelsGCST904705434.96e-03
11697EDAR/IRAK4 ratioGCST903145794.95e-03
11698DTI autoptx L2 cgc r tractGCST903851714.94e-03
11699CRADD/MAP4K5 ratioGCST903142404.94e-03
11700Eosinophil percentage of white cellsGCST900023824.93e-03
11701CCL24 levelsGCST904685764.93e-03
11702Treatment/medication code - allopurinol | MedicationsUKBB000008394.93e-03
11703CST3/DEFA1_DEFA1B ratioGCST903142914.92e-03
11704ANXA3/ANXA4 ratioGCST903132784.90e-03
11705Basophill percentage | Blood countUKBB000000874.89e-03
11706TYRP1 levelsGCST904709984.88e-03
11707PEAR1/TREML2 ratioGCST903156454.87e-03
11708Basophil percentage of white cellsGCST900023804.87e-03
11709Poisoning by antibiotics | injuries & poisoningsUKBB000006534.87e-03
11710Bipolar and major depression status - No Bipolar or Depression | Mental healthUKBB000000944.86e-03
11711Alzheimer's disease (late onset)GCST0022454.85e-03
11712Recent feelings of depression | DepressionUKBB000007374.84e-03
11713CRADD/EDAR ratioGCST903142354.83e-03
11714Linoleic acid to total fatty acids percentageGCST905023364.82e-03
11715Acute upper respiratory infections of multiple and unspecified sitesFING000000354.81e-03
11716Linoleic acid levelsGCST905023104.80e-03
11717IL17RB levelsGCST904695634.80e-03
11718Bread type - Wholemeal or wholegrain | DietUKBB000001074.79e-03
11719DTI autoptx L3 ifo r tractGCST903852064.79e-03
11720Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T461ECGA0004614.78e-03
11721EXTL1 levelsGCST904691614.78e-03
11722Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468ECGA0004684.78e-03
11723Pregnenediol sulfate (C21H34O5S) levelsGCST901998614.77e-03
11724Other hypertrophic and atrophic conditions (PheCode 701)GCST904761974.77e-03
11725Plasma homoarginine levels in chronic kidney diseaseGCST902653454.77e-03
11726X-14626 levelsGCST902438614.76e-03
11727Principal component-derived dietary pattern 28GCST901330334.76e-03
11728CD79B levelsGCST904686484.75e-03
11729Total Dihexosylceramide levelsGCST900258214.75e-03
11730Other hypothyroidism | Disorders of thyroid glandUKBB000006114.74e-03
11731Medication use (immunosuppressants)GCST900187714.73e-03
11732S100G levelsGCST904705194.73e-03
11733ADA2/COMP ratioGCST903131664.71e-03
11734CPA1/CTRB1 ratioGCST903142034.71e-03
11735ATOX1/SPARC ratioGCST903133754.71e-03
11736F2R/TMSB10 ratioGCST903147384.69e-03
11737ATG4A/NSFL1C ratioGCST903133684.68e-03
11738CD8A levelsGCST904686554.67e-03
11739CXCL5/MESD ratioGCST903143504.66e-03
11740Blood cell traits latent factor 8 (white cell)GCST905592504.65e-03
11741FADD/PPP1R2 ratioGCST903147744.65e-03
11742aparc-a2009s rh area G-postcentralGCST900033984.65e-03
11743DCXR/KYNU ratioGCST903144384.64e-03
11744CXCL11/ITGB1BP2 ratioGCST903143354.63e-03
11745VNN2 levelsGCST904710444.62e-03
11746HNRNPK/USP8 ratioGCST903150704.62e-03
11747CLEC4G/NELL2 ratioGCST903141224.59e-03
11748CD160/NCR1 ratioGCST903137324.59e-03
11749CRTAM/ICAM3 ratioGCST903142764.59e-03
11750Fasciitis (PheCode 728.7)GCST904762444.58e-03
11751Other follicular disordersFING000010504.58e-03
11752Type of accommodation lived in - A flat, maisonette or apartment | HouseholdUKBB000008684.56e-03
11753Feeling lonelyGCST0069424.55e-03
11754Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB000003714.54e-03
11755BCAM/LGALS4 ratioGCST903134734.53e-03
11756CASP3/MESD ratioGCST903136364.52e-03
11757FOLR2 levelsGCST904692604.52e-03
11758Hypothyroidism NOS | endocrine/metabolicUKBB000003364.50e-03
11759Blood glucose levelsGCST900259864.50e-03
11760FCRL5 levelsGCST904692084.49e-03
11761VEGFC/ZBTB16 ratioGCST903159464.48e-03
11762IRAG2/TBC1D23 ratioGCST903151914.44e-03
11763DTI TBSS L1 Body of corpus callosumGCST903844314.44e-03
11764First line medication for Crohn's diseaseFING000005444.43e-03
11765Asthma-related infectionsFING000001184.43e-03
11766Crohn's disease of small intestineFING000003694.43e-03
11767DECR1/STX8 ratioGCST903144524.43e-03
11768Other disorders of skin and subcutaneous tissue, not elsewhere classifiedFING000010364.42e-03
11769Eosinophil countGCST0046064.41e-03
11770Oranges likingGCST900948074.40e-03
11771Seen a psychiatrist for nerves, anxiety, tension or depression | Mental healthUKBB000007644.39e-03
11772Other and unspecified tonsillitisFING000009544.39e-03
11773T1 FreeSurfer aseg lhCerebralWhiteMatterVolGCST903841854.39e-03
11774Other eye problems | EyesightUKBB000006104.38e-03
11775NUCB2/RSPO3 ratioGCST903155754.36e-03
11776SPRY2/YTHDF3 ratioGCST903158814.35e-03
11777MBL2 levelsGCST904698684.35e-03
11778IDP dMRI TBSS ISOVF Superior cerebellar peduncle LGCST900044904.34e-03
11779T1 CAT volume L VIIIaGCST903841274.34e-03
11780AsthmaGCST904752594.33e-03
11781JCHAIN levelsGCST904696614.33e-03
11782lymphocyte (absolute count, minimum, inv-norm transformed)GCST904754294.33e-03
11783CD300E levelsGCST904686214.32e-03
11784CD63/EDAR ratioGCST903138644.30e-03
11785Physical activity (Total log acceleration 6pm-8pm)GCST900614184.30e-03
11786FOXO3/MAP3K5 ratioGCST903148804.28e-03
11787Lichen ruber planus, wide definition including periferal and oral lichen planusFING000007224.27e-03
11788Type 2 diabetes | endocrine/metabolicUKBB000008674.27e-03
11789Soy sauce likingGCST900948444.25e-03
11790PRSS8 levelsGCST904703454.24e-03
11791Hashimoto thyroiditisGCST900186354.24e-03
11792ACHE levelsGCST904681994.23e-03
11793S100A11/S100A12 ratioGCST903157984.23e-03
11794Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460ECGA0004604.22e-03
11795Spondylopathies (FG)FING000013264.22e-03
11796AHSG levelsGCST904682634.19e-03
11797lymphocyte (fraction, minimum, inv-norm transformed)GCST904754384.19e-03
11798Duration walking for pleasure | Physical activityUKBB000002034.18e-03
11799Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329684.16e-03
11800Actinic keratosisFING000000134.15e-03
11801CNDP1/F9 ratioGCST903141474.14e-03
11802NELL2/SEZ6L ratioGCST903155364.14e-03
11803neutrophil (fraction, mean, inv-norm transformed)GCST904755384.13e-03
11804ITGB6 levelsGCST904696464.13e-03
11805ARNT levelsGCST904683674.12e-03
11806N6-methyllysine levels in chronic kidney diseaseGCST902575304.12e-03
11807FCRL6/KLRD1 ratioGCST903148074.12e-03
11808Number in household | HouseholdUKBB000005304.12e-03
11809DepressionGCST0037694.11e-03
11810KLK8 levelsGCST904254924.11e-03
11811IL2RA/NCR1 ratioGCST903151614.10e-03
11812MYBPC1 levelsGCST904699694.08e-03
11813CLEC1B/HBEGF ratioGCST903140924.08e-03
11814Treatment speciality of consultant (recoded) - Dermatology | Summary AdministrationUKBB000008304.07e-03
11815Clonal haematopoiesis of indeterminate potential (ASXL1 mutation)GCST901652594.06e-03
11816PGLYRP1 levelsGCST904702194.06e-03
11817Fluid intelligence score | Fluid intelligence / reasoningUKBB000002504.05e-03
11818MICB_MICA/TEK ratioGCST903154464.05e-03
11819ZNF830 levelsGCST904711024.04e-03
11820Loneliness (standard GWA)GCST902672884.04e-03
11821BCR/FOXO1 ratioGCST903134904.04e-03
11822UrticariaFING000014084.03e-03
11823Urine N-acetyl-cadaverine levels in chronic kidney diseaseGCST902655414.02e-03
11824Carnitine levelsGCST901996214.00e-03
11825Hypothyroidism | endocrine/metabolicUKBB000003354.00e-03
11826MAX/TDRKH ratioGCST903154064.00e-03
11827CA9/CBLIF ratioGCST903135953.99e-03
11828Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING000007643.98e-03
11829ABHD14B/APRT ratioGCST903131373.96e-03
11830Basal cell carcinomaGCST904681143.95e-03
11831DAB2/VASH1 ratioGCST903143693.92e-03
11832chloride (mean, inv-norm transformed)GCST904751943.91e-03
11833Number of days/week walked 10+ minutes | Physical activityUKBB000005353.91e-03
11834CCN2/TPP1 ratioGCST903137183.91e-03
11835DKK1/PDGFA ratioGCST903144753.90e-03
11836Varicose veins of lower extremity, symptomtic (PheCode 454.11)GCST904760143.89e-03
11837aparc-a2009s lh area S-precentral-sup-partGCST900033653.88e-03
11838DTI TBSS L3 Genu of corpus callosumGCST903845263.86e-03
11839AmygNuclei lh volume Whole-amygdalaGCST900026573.86e-03
11840CholelithiasisGCST900185993.85e-03
11841Mouth/teeth dental problems - Mouth ulcers | MouthUKBB000004883.85e-03
11842DIABLO/DOK2 ratioGCST903144643.85e-03
11843Prescriptions - thyroid hormone | hormoneUKBB000007053.83e-03
11844Prescriptions - levothyroxine | thyroid hormoneUKBB000006873.83e-03
11845Glucose levels (UKB data field 23470)GCST902695673.81e-03
11846CXCL5/PPIB ratioGCST903143523.81e-03
11847Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020743.81e-03
11848HSBP1 levelsGCST904694813.80e-03
11849Number of operations, self-reported | OperationsUKBB000005393.78e-03
11850KLK13 levelsGCST904696993.78e-03
11851MRPL33 levelsGCST906179863.76e-03
11852Ever suffered mental distress preventing usual activities | Mental distressUKBB000002233.74e-03
11853CEP43/USP8 ratioGCST903140223.73e-03
11854ART3/GPC1 ratioGCST903133613.73e-03
11855Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465ECGA0004653.73e-03
11856Thyrotoxicosis with toxic multinodular goitreFING000013623.72e-03
11857GYS1/PPP1R2 ratioGCST903150013.71e-03
11858CD22/TCL1A ratioGCST903137603.71e-03
11859Non-insulin-dependent diabetes mellitus | Diabetes mellitusUKBB000005243.70e-03
11860CD101 levelsGCST904685963.70e-03
11861DTI autoptx L1 atr r tractGCST903851423.69e-03
11862IridocyclitisFING000006963.67e-03
11863BCR/PLXNA4 ratioGCST903134973.67e-03
11864Red meat likingGCST900948193.66e-03
11865PlateletcritGCST0046073.65e-03
11866Platelet distribution widthGCST900024013.64e-03
11867IDP dMRI TBSS OD Posterior corona radiata LGCST900044293.64e-03
11868Oral glucose tolerance test-2hGCST902977903.63e-03
11869CD5 levelsGCST904686413.62e-03
11870GNLY levelsGCST904693723.62e-03
11871Fasting plasma glucoseGCST905664203.62e-03
11872Conduction disordersFING000003243.61e-03
11873ALCAM/ICAM3 ratioGCST903132373.61e-03
11874Principal component-derived dietary pattern 24GCST901330293.58e-03
11875CD27 levelsGCST904686153.57e-03
11876Treatment/medication code - levothyroxine sodium | MedicationsUKBB000008493.56e-03
11877STX6 levelsGCST904707743.55e-03
11878ULBP2 levelsGCST904710083.55e-03
11879Platelet distribution widthGCST0046163.54e-03
11880CD79B/TNFRSF4 ratioGCST903139033.54e-03
11881DIABLO/GRAP2 ratioGCST903144663.53e-03
11882Diabetes mellitus | endocrine/metabolicUKBB000001693.53e-03
11883Mean sphered cell volume | Blood countUKBB000004523.52e-03
11884PIK3AP1/PSMG3 ratioGCST903156513.51e-03
11885PPME1/PSMD9 ratioGCST903157053.50e-03
11886CD163/ICAM1 ratioGCST903137353.50e-03
11887Rheumatoid arthritisGCST901322243.50e-03
11888Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB000005183.49e-03
11889IL18 levelsGCST904695673.49e-03
11890SRPK2/VASH1 ratioGCST903158863.49e-03
11891Irritable bowel syndrome mixed subtypeGCST902439593.48e-03
11892DTI TBSS MD Anterior limb of internal capsule RGCST903845883.48e-03
11893Autoimmune diseasesFING000001313.47e-03
11894CRELD2/F2R ratioGCST903142543.46e-03
11895CLEC4G/LGALS4 ratioGCST903141203.46e-03
11896IL6 levelsGCST904696043.46e-03
11897Childhood asthma (age<16) (more control exclusions)FING000002703.46e-03
11898Cucumber likingGCST900947493.45e-03
11899LDLR levelsGCST904697503.42e-03
11900HLA-A levelsGCST904694573.40e-03
11901CEP43/MPHOSPH8 ratioGCST903140193.39e-03
11902TCL1A levelsGCST904708173.39e-03
11903Principal component-derived dietary pattern 21GCST901330263.37e-03
11904EDAR/F2R ratioGCST903145773.37e-03
11905CD58/IFNGR1 ratioGCST903138493.36e-03
11906aparc-Desikan rh area postcentralGCST900031283.35e-03
11907eosinophil (fraction, mean, inv-norm transformed)GCST904753003.30e-03
11908Social and economic stability (confirmatory factor analysis Factor 15)GCST903093493.30e-03
11909IDP dMRI TBSS OD Posterior limb of internal capsule LGCST900044213.30e-03
11910CDKN1A/TACC3 ratioGCST903139753.29e-03
11911ACE2/MME ratioGCST903131543.29e-03
11912lymphocyte (fraction, maximum, inv-norm transformed)GCST904754323.29e-03
11913DBI/EDAR ratioGCST903144083.29e-03
11914Other maternal disorders predominantly related to pregnancyFING000010693.28e-03
11915Mean sphered cell volume (UKB data field 30270)GCST904680893.28e-03
11916Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB000001923.28e-03
11917aparc-a2009s lh volume S-precentral-sup-partGCST900029933.27e-03
11918F2R/SPINT2 ratioGCST903147373.25e-03
11919Placental weight (paternal genotype, adjusted for sex and gestational age)GCST902751913.21e-03
11920REST UKBBICA NODEamps25 0005GCST903854883.21e-03
11921DTI TBSS MD Posterior limb of internal capsule LGCST903845913.19e-03
11922PollinosisGCST900186833.19e-03
11923EPHB6/LAYN ratioGCST903146813.18e-03
11924SCARF1/TNFRSF14 ratioGCST903158123.18e-03
11925LifespanGCST905518853.18e-03
11926MAVS/MYO9B ratioGCST903153903.17e-03
11927BANK1/FOXO1 ratioGCST903134563.16e-03
11928CDH17/PTPRM ratioGCST903139433.15e-03
11929Asthma (only as main-diagnosis) (more control exclusions)FING000001143.15e-03
11930ITGB1BP2/TIA1 ratioGCST903152223.14e-03
11931Eosinophil countGCST900022993.13e-03
11932Salad / raw vegetable intake | DietUKBB000007613.13e-03
11933Frontotemporal dementiaFING000005603.12e-03
11934EFNA4/VWC2 ratioGCST903146073.12e-03
11935DEFA1_DEFA1B/PTGDS ratioGCST903144553.11e-03
11936CD300LF levelsGCST904686223.11e-03
11937LGALS4 levelsGCST904697623.11e-03
11938ICAM3/NOTCH1 ratioGCST903151223.10e-03
11939CLEC4D/CLEC6A ratioGCST903141093.10e-03
11940IL15/IL18BP ratioGCST903151483.10e-03
11941IL27 levelsGCST904690603.08e-03
11942Cheesecake likingGCST900947303.07e-03
11943Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)FING000007493.06e-03
11944CD300C/HAVCR2 ratioGCST903137893.04e-03
11945Frequency of unenthusiasm / disinterest in last 2 weeks | Mental healthUKBB000002703.03e-03
11946AGXT/GSTA1 ratioGCST903132063.03e-03
11947Time spent watching television (TV) | Physical activityUKBB000008213.02e-03
11948AK1/PEBP1 ratioGCST903132253.01e-03
11949CCL3 levelsGCST904685822.99e-03
11950Positional arithmetic | Fluid intelligence / reasoningUKBB000006542.99e-03
11951Platelet distribution width (UKB data field 30110)GCST904680972.99e-03
11952Chronic nephritic syndromeFING000002952.98e-03
11953GYS1/TIA1 ratioGCST903150042.98e-03
11954DKK1/ZBTB16 ratioGCST903144862.97e-03
11955Burger likingGCST900947152.96e-03
11956Bifidobacterium kashiwanohense abundance in stoolGCST900322262.96e-03
11957lymphocyte (fraction, mean, inv-norm transformed)GCST904754352.95e-03
11958Spicy food likingGCST900948462.92e-03
11959Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463ECGA0004632.92e-03
11960IDP dMRI TBSS ISOVF Genu of corpus callosumGCST900044792.90e-03
11961Excessive sweatingGCST0060902.89e-03
11962Type 1 diabetesGCST900137912.89e-03
11963HGF levelsGCST904694492.88e-03
11964Irritable bowel syndromeGCST902439582.87e-03
11965CEACAM8 levelsGCST904686982.85e-03
11966GZMH/KLRD1 ratioGCST903150162.84e-03
11967Allergy/adverse effect of penicillin | injuries & poisoningsUKBB000000282.84e-03
11968Noninfectious disorders of lymphatic channels (PheCode 450)GCST904760022.83e-03
11969Systemic lupus erythematosusGCST900118662.83e-03
11970CD1C/CD207 ratioGCST903137452.83e-03
11971Basophil countGCST900023792.82e-03
11972CLEC4G/KDR ratioGCST903141182.82e-03
11973WFIKKN2 levelsGCST904710772.81e-03
11974EDAR/TXNDC5 ratioGCST903145932.80e-03
11975Asthma/COPD (KELA code 203)FING000001212.80e-03
11976BA-exvivo rh area BA4aGCST900032252.80e-03
11977FCER2 levelsGCST904691992.80e-03
11978CCL2 levelsGCST904685812.79e-03
11979eosinophil (fraction, maximum, inv-norm transformed)GCST904752972.78e-03
11980CLEC11A levelsGCST904687642.77e-03
11981Alanine levelsGCST900928062.77e-03
11982HBEGF/PDGFA ratioGCST903150332.76e-03
11983Glycated haemoglobin HbA1c levels (UKB data field 30750)GCST904680722.76e-03
11984CEACAM6 levelsGCST904686972.75e-03
11985Plasma X-24947 levels in chronic kidney diseaseGCST902668162.75e-03
11986CLSTN2 levelsGCST904687892.75e-03
11987Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB000008602.74e-03
11988Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461ECGU0004612.74e-03
11989Monocyte countGCST900187472.73e-03
11990CD209 levelsGCST904686082.69e-03
11991Soya milk likingGCST900948452.67e-03
11992Birth weight known - Yes - pounds and ounces | Early life factorsUKBB000000972.66e-03
11993GPKOW levelsGCST904693922.65e-03
11994CD300E/EFNA4 ratioGCST903137972.63e-03
11995Viral warts & HPV (PheCode 78)GCST904755552.62e-03
11996CLEC4G/MERTK ratioGCST903141212.61e-03
11997Birth weight known - No | Early life factorsUKBB000000962.61e-03
11998PlateletcritGCST900024002.61e-03
11999MGLL/STK4 ratioGCST903154432.60e-03
12000Crohn's disease NASFING000003672.60e-03